31 May [44] New Drugs VII – Mirtazapine (Remeron®), Salmon-Calcitonin Nasal Spray (Miacalcin®), Gatifloxacin (Tequin®), Moxifloxacin
Mirtazapine (Remeron®) Approved indication: “Symptomatic relief of depressive illness.” 1 Mechanism of action: As with all antidepressants the mechanism of therapeutic benefit is unknown. It is an inhibitor of a number of receptors including adrenergic, serotonergic, histaminic and muscarinic....